Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00894855 · ClinicalTrials.gov registry record · NA

Skin Cancer Screening and Education at Beaches

A NA study, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
634
Enrollment target

NCT00894855: Completed NA study, sponsored by Dana-Farber Cancer Institute.

NCT00894855 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 634 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00894855, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
634 participants
Enrollment target

Study Summary

This study was an evaluation of the Dana-Farber Cancer Institute Blum Family Resource Center Van's existing skin cancer screening and education program. This program occurred over 2 summers. This study will fill a critical gap in the investigators' knowledge about how best to address the high-risk behaviors that regularly occur during the summertime at beaches. The investigators randomized beaches to receive different combinations of the van program components in order to determine how services should optimally be configured to maximize impact. The investigators hypothesized that providing all three components (1-Skin cancer prevention education; 2-Biometric feedback using a Dermascan Analyzer that illustrates skin damage due to sun exposure and Ultra Violet (UV) Reflectance Photography; and 3-Dermatologist skin exam) will maximize knowledge and behavior change, relative to education alone.

Interventions

  • BEHAVIORAL education about sun protection
  • BEHAVIORAL biometric feedback
  • OTHER dermatologist skin exam

Trial Details

FieldValue
Enrollment Target 634 participants
Start Date 2007-01
Est. Completion 2008-11
Phase NA
Dana-Farber Cancer Institute

781 total trials

What the finished NCT00894855 record still lists

NCT00894855 is an interventional study that assigns participants to a tested intervention. The registered 634 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).

The record links to 0 conditions, and to 3 interventions - of which education about sun protection is the first listed.

NCT00894855 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00894855 about?

NCT00894855 is a clinical study titled "Skin Cancer Screening and Education at Beaches". This study was an evaluation of the Dana-Farber Cancer Institute Blum Family Resource Center Van's existing skin cancer screening and education program. This program occurred over 2 summers. This study will fill a critical gap in the investigators' knowledge about how best to address the high-risk b...

What is the current status of trial NCT00894855?

This trial is currently completed. It is a NA study. The enrollment target is 634 participants. The study started on 2007-01. Estimated completion is 2008-11.

What interventions are being tested in trial NCT00894855?

The interventions under investigation include: education about sun protection (BEHAVIORAL), biometric feedback (BEHAVIORAL), dermatologist skin exam (OTHER).

Who is sponsoring clinical trial NCT00894855?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00894855's enrollment target sits among peer trials

634 158th of 2000 higher than 1,842 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573027 · 634 participants · NA

    Heart Disease of the Small Arteries in Women and Men

  • NCT04108156 · 634 participants · Phase 3

    A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME

  • NCT07237295 · 634 participants · NA

    CommunityRx-Kidney Health

  • NCT03478826 · 635 participants

    Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00894855, the US trial registry maintained by the National Library of Medicine. NCT00894855 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.